Schizophrenia Research
Volume 66, Issue 1 , Pages 77-78 , 1 January 2004

Bone mineral density and prolactin associations in patients with chronic schizophrenia

  • Oliver Howes

      Affiliations

    • Corresponding Author InformationTel.: +44-20-7848-0080; mobile: +44-7811-576-222.

Received 15 December 2002

References 

  1. Abraham G, Halbreich U, Friedman RH, Josiassen RC. Bone mineral density and prolactin associations in patients with chronic schizophrenia. Schizophr. Res. 2003;59:17–18
  2. Colao A, di Somma C, Loche S, di Sarno A, Klain M, Pivonello R, et al. Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clin. Endocrinol. (Oxf.). 2000;52:319–327
  3. Goodnick PJ, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels. Expert Opin. Pharmacother. 2002;3:1381–1391
  4. Howes O, Simpson L, Meaney A, O'Keane V, Murray R, Smith S. Are prolactin raising antipsychotics associated with osteoporosis?. J. Psychopharmacol. 2002;16(3):23; (Ref Type: Abstract)
  5. Karunakaran S, Page RC, Wass JA. The effect of the menopause on prolactin levels in patients with hyperprolactinaemia. Clin. Endocrinol. (Oxf.). 2001;54:295–300
  6. Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. Schizophr. Res. 2002;56:11–17

PII: S0920-9964(03)00054-9

doi: 10.1016/S0920-9964(03)00054-9

Schizophrenia Research
Volume 66, Issue 1 , Pages 77-78 , 1 January 2004

Article Tools